Patent Act of 1952 -- Patentable Subject Matter -- Ass'n for Molecular Pathology v. Myriad Genetics, Inc.
The article discusses the U.S. Supreme Court's ruling in the 2013 case Ass'n for Molecular Pathology v. Myriad Genetics Inc. which deals with the nation's Patent Act of 1952, patentable subject matter in the U.S., and biotechnology-related innovations. According to the article, the court determined...
| Published in: | Harvard Law Review Vol. 127; no. 1; pp. 388 - 408 |
|---|---|
| Format: | Article |
| Published: |
Harvard Law Review Association
Nov2013
|
| Subjects: | |
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=hlh&AN=92509448&site=ehost-live header: @attributes: shortDbName: hlh uiTerm: 92509448 longDbName: Humanities International Complete uiTag: AN controlInfo: bkinfo: jinfo: jid: 0017811X HLR jtl: Harvard Law Review issn: 0017811X maglogo: N pubinfo: dt: Nov2013 vid: 127 iid: 1 pid: 2349 pub: Harvard Law Review Association artinfo: ui: 92509448 ppf: 388 ppct: 20 formats: tig: atl: Patent Act of 1952 -- Patentable Subject Matter -- Ass'n for Molecular Pathology v. Myriad Genetics, Inc. aug: su: Association for Molecular Pathology v. Myriad Genetics Inc. Patentability -- Lawsuits & claims Molecules United States. Supreme Court Actions & defenses (Law) Patent law State statutes (United States) Biotechnology laws Law United States sug: subj: United States Association for Molecular Pathology v. Myriad Genetics Inc. Patentability -- Lawsuits & claims Molecules United States. Supreme Court Actions & defenses (Law) Patent law State statutes (United States) Biotechnology laws Law ab: The article discusses the U.S. Supreme Court's ruling in the 2013 case Ass'n for Molecular Pathology v. Myriad Genetics Inc. which deals with the nation's Patent Act of 1952, patentable subject matter in the U.S., and biotechnology-related innovations. According to the article, the court determined that molecules which are isolated from native DNA are not patent eligible, but certain molecules that are synthesized in a laboratory can be patented. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: Y dt: @attributes: year: 2013 holdings: @attributes: islocal: N |
|---|